Literature DB >> 8234708

Change induced by radiation therapy in FDG uptake in normal and malignant structures of the head and neck: quantitation with PET.

S D Rege1, L Chaiken, C K Hoh, Y Choi, R Lufkin, Y Anzai, G Juillard, J Maddahi, M E Phelps, R A Hawkins.   

Abstract

PURPOSE: To quantitate the changes induced in uptake of the glucose analog 2-[fluorine-18]fluoro-2-deoxy-D-glucose (FDG) in normal structures in the head and neck and compare these to the change in uptake in malignant structures in patients with head and neck tumors undergoing radiation therapy.
MATERIALS AND METHODS: Eleven patients with biopsy-confirmed squamous cell carcinoma of the head and neck were studied before, during, and after a 6-week course of radiation therapy with positron emission tomography (PET)-FDG imaging. A ratio of FDG uptake in the structure compared with that in the cerebellum (termed metabolic ratio) within and outside of the field of radiation was determined in the adenoids; lingual and palatine tonsils; parotid, submandibular, and sublingual glands; and nasal turbinates, soft palate, and gingiva.
RESULTS: The average metabolic ratio in the tonsils, nasal turbinates, soft palate, and gingiva did not change significantly with treatment.
CONCLUSION: FDG uptake in normal structures does not change with radiation therapy. This fact is in marked contrast to the FDG uptake in squamous cell carcinomas in the head and neck, which decrease dramatically with treatment (P < .005).

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8234708     DOI: 10.1148/radiology.189.3.8234708

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  10 in total

Review 1.  Positron emission tomography (PET): expanding the horizons of oncology drug development.

Authors:  Lisa A Hammond; Louis Denis; Umber Salman; Paul Jerabek; Charles R Thomas; John G Kuhn
Journal:  Invest New Drugs       Date:  2003-08       Impact factor: 3.850

Review 2.  The role of FDG PET-CT in the therapeutic evaluation for HNSCC patients.

Authors:  Joji Kawabe; Shigeaki Higashiyama; Atsushi Yoshida; Kohei Kotani; Susumu Shiomi
Journal:  Jpn J Radiol       Date:  2012-04-05       Impact factor: 2.374

3.  A radiobiological model of radiotherapy response and its correlation with prognostic imaging variables.

Authors:  Mireia Crispin-Ortuzar; Jeho Jeong; Andrew N Fontanella; Joseph O Deasy
Journal:  Phys Med Biol       Date:  2017-01-31       Impact factor: 3.609

4.  Image fusion for computer-assisted bone tumor surgery.

Authors:  Kwok Chuen Wong; Shekhar Madhuker Kumta; Gregory Ernest Antonio; Lung Fung Tse
Journal:  Clin Orthop Relat Res       Date:  2008-07-22       Impact factor: 4.176

Review 5.  Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose.

Authors:  P Rigo; P Paulus; B J Kaschten; R Hustinx; T Bury; G Jerusalem; T Benoit; J Foidart-Willems
Journal:  Eur J Nucl Med       Date:  1996-12

6.  Positron emission tomographic imaging of head and neck lesions.

Authors:  H Sakamoto; Y Nakai; Y Ohashi; T Okamura; H Ochi
Journal:  Eur Arch Otorhinolaryngol       Date:  1997       Impact factor: 2.503

7.  [Volume changes to the neck lymph node metastases in head-neck tumors. The evaluation of radiotherapeutic treatment success].

Authors:  G Liszka; U Thalacker; A Somogyi; G Németh
Journal:  Strahlenther Onkol       Date:  1997-08       Impact factor: 3.621

8.  Feasibility of simultaneous PET/MR imaging in the head and upper neck area.

Authors:  Andreas Boss; Lars Stegger; Sotirios Bisdas; Armin Kolb; Nina Schwenzer; Markus Pfister; Claus D Claussen; Bernd J Pichler; Christina Pfannenberg
Journal:  Eur Radiol       Date:  2011-02-10       Impact factor: 5.315

9.  [Value of 18F fluorodeoxyglucose positron emission tomography in radiotherapy planning of head-neck tumors].

Authors:  A N Rahn; R P Baum; I A Adamietz; S Adams; S Sengupta; S Mose; S B Bormeth; G Hör; H D Böttcher
Journal:  Strahlenther Onkol       Date:  1998-07       Impact factor: 3.621

10.  18FDG positron emission tomography mining for metabolic imaging biomarkers of radiation-induced xerostomia in patients with oropharyngeal cancer.

Authors:  Hesham Elhalawani; Carlos E Cardenas; Stefania Volpe; Souptik Barua; Sonja Stieb; Calvin B Rock; Timothy Lin; Pei Yang; Haijun Wu; Jhankruti Zaveri; Baher Elgohari; Lamiaa E Abdallah; Amit Jethanandani; Abdallah S R Mohamed; Laurence E Court; Katherine A Hutcheson; G Brandon Gunn; David I Rosenthal; Steven J Frank; Adam S Garden; Arvind Rao; Clifton D Fuller
Journal:  Clin Transl Radiat Oncol       Date:  2021-06-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.